name:-0.079667091369629
name:-0.012269973754883
name:-0.016914844512939
Berlin; Michael Patent Filings

Berlin; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Berlin; Michael.The latest application filed is for "compounds and methods for the targeted degradation of androgen receptor".

Company Profile
16.11.36
  • Berlin; Michael - Flemington NJ
  • Berlin; Michael - Rahway NJ
  • Berlin; Michael - West Hollywood CA
  • Berlin; Michael - Beverly Hills CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Compounds and methods for the targeted degradation of androgen receptor
Grant 11,427,548 - Crew , et al. August 30, 2
2022-08-30
Compounds And Methods For The Targeted Degradation Of Androgen Receptor
App 20220259154 - BERLIN; Michael ;   et al.
2022-08-18
Alanine-based Modulators Of Proteolysis And Associated Methods Of Use
App 20220162163 - Berlin; Michael ;   et al.
2022-05-26
Selective Modulators Of Mutant Lrrk2 Proteolysis And Associated Methods Of Use
App 20220064168 - Araujo; Erika ;   et al.
2022-03-03
Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide
Grant 11,191,741 - Crew , et al. December 7, 2
2021-12-07
Compounds And Methods For The Targeted Degradation Of Bromodomain-containing Proteins
App 20210187108 - Qian; Yimin ;   et al.
2021-06-24
Compounds And Methods For The Targeted Degradation Of Androgen Receptor
App 20210171470 - Crew; Andrew P. ;   et al.
2021-06-10
Imidazo[1,2-c]quinazolin-5-amine Compounds With A2a Antagonist Properties
App 20210053973 - ALI; Amjad ;   et al.
2021-02-25
Compounds And Methods For The Targeted Degradation Of Androgen Receptor
App 20210040044 - Crew; Andrew P. ;   et al.
2021-02-11
Compounds And Methods For The Targeted Degradation Of Androgen Receptor
App 20210009528 - CREW; Andrew P. ;   et al.
2021-01-14
Compounds And Methods For The Enhanced Degradation Of Targeted Proteins
App 20200392131 - Crew; Andrew P. ;   et al.
2020-12-17
Compounds and methods for the targeted degradation of bromodomain-containing proteins
Grant 10,772,962 - Qian , et al. September 15, 2
2020-09-15
Compounds and methods for the enhanced degradation of targeted proteins
Grant 10,730,870 - Crew , et al.
2020-08-04
Aminopyrazine compounds with A2A antagonist properties
Grant 10,688,082 - Zheng , et al.
2020-06-23
Cereblon Ligands And Bifunctional Compounds Comprising The Same
App 20200155690 - Crew; Andrew P. ;   et al.
2020-05-21
Cereblon Ligands And Bifunctional Compounds Comprising The Same
App 20200155689 - CREW; ANDREW P. ;   et al.
2020-05-21
Compounds And Methods For The Targeted Degradation Of Androgen Receptor
App 20200095205 - CREW; Andrew P. ;   et al.
2020-03-26
Modulators Of Alpha-synuclein Proteolysis And Associated Methods Of Use
App 20200085793 - Crew; Andrew P. ;   et al.
2020-03-19
Compounds And Methods For The Targeted Degradation Of Androgen Receptor
App 20200055825 - Crew; Andrew P. ;   et al.
2020-02-20
Brm Targeting Compounds And Associated Methods Of Use
App 20200038378 - CREW; ANDREW P. ;   et al.
2020-02-06
Aminopyrazine compounds with A2A antagonist properties
Grant 10,472,347 - Kuang , et al. Nov
2019-11-12
Modulators Of Proteolysis And Associated Methods Of Use
App 20190315732 - Crew; Andrew P. ;   et al.
2019-10-17
Brm Targeting Compounds And Associated Methods Of Use
App 20190300521 - Crew; Andrew P. ;   et al.
2019-10-03
Compounds And Methods For The Targeted Degradation Of Androgen Receptor
App 20180346461 - Crew; Andrew P. ;   et al.
2018-12-06
Aminoquinazoline compounds as A.sub.2A antagonist
Grant 10,138,212 - Ali , et al. Nov
2018-11-27
Aminopyrazine Compounds With A2a Antagonist Properties
App 20180327385 - KUANG; Rongze ;   et al.
2018-11-15
Cereblon Ligands And Bifunctional Compounds Comprising The Same
App 20180228907 - Crew; Andrew P. ;   et al.
2018-08-16
Cereblon Ligands And Bifunctional Compounds Comprising The Same
App 20180215731 - Crew; Andrew P. ;   et al.
2018-08-02
Egfr Proteolysis Targeting Chimeric Molecules And Associated Methods Of Use
App 20180193470 - Crew; Andrew P. ;   et al.
2018-07-12
Aminopyrazine Compounds With A2a Antagonist Properties
App 20180193314 - Zheng; Junying ;   et al.
2018-07-12
Compounds And Methods For The Targeted Degradation Of Enhancer Of Zeste Homolog 2 Polypeptide
App 20180177750 - Crew; Andrew P. ;   et al.
2018-06-28
Tau-protein Targeting Protacs And Associated Methods Of Use
App 20180125821 - Crew; Andrew P. ;   et al.
2018-05-10
Compounds And Methods For The Targeted Degradation Of Androgen Receptor
App 20180099940 - Crew; Andrew P. ;   et al.
2018-04-12
Aminoquinazoline Compounds As A2a Antagonist
App 20180037554 - Ali; Amjad ;   et al.
2018-02-08
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A.sub.2A antagonist properties
Grant 9,676,780 - Ali , et al. June 13, 2
2017-06-13
Glaucoma surgery methods and systems
Grant 9,642,746 - Berlin May 9, 2
2017-05-09
Glaucoma Surgery Methods and Systems
App 20170119579 - Berlin; Michael
2017-05-04
Compounds And Methods For The Targeted Degradation Of Bromodomain-containing Proteins
App 20170065719 - Qian; Yimin ;   et al.
2017-03-09
Alanine-based Modulators Of Proteolysis And Associated Methods Of Use
App 20170037004 - Crew; Andrew P. ;   et al.
2017-02-09
Compounds And Methods For The Enhanced Degradation Of Targeted Proteins
App 20160272639 - Crew; Andrew P. ;   et al.
2016-09-22
Piperazine-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties
App 20160194330 - Ali; Amjad ;   et al.
2016-07-07
Glaucoma Surgery Methods and Systems
App 20140288485 - Berlin; Michael
2014-09-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed